The growing demand for specific immunological investigation and therapeutic creation has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently produced using multiple expression methods, including bacterial hosts, mammalian cell cultures, and v